Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Illiger

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Der Internist|September 9, 2000
[Quality assurance in oncology--medical oncology in particular]H J Illiger
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 11, 2002
[Superiority of letrozole compared with tamoxifen as first line therapy of postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group]H J Illiger
Medizinische Klinik (Munich, Germany : 1983)|January 15, 1994
[Ambulatory and/or inpatient oncologic treatment?]H J Illiger
Der Internist|February 12, 1998
[Monoclonal antibody 17-1A (Panorex). A new approach to adjuvant therapy of colonic carcinoma]H J Illiger
Der Internist|May 1, 1997
[Glucocorticoids in hematology and medical oncology]H J Illiger
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 29, 2000
[Primary prevention of breast cancer in women with an increased risk for breast cancer--a prospective, randomized, double-blind study (NSABP-P1 study)]D Reichert, H J Illiger
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 8, 2001
[Vinorelbine in patients with malignant pleural mesothelioma--a phase II study]E Ost, H J Illiger
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 10, 2001
[IFN-alpha consolidation after intensive chemotherapy does not bring any survival advantage in low-grade non-Hodgkin lymphoma]M Klee, H J Illiger
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 12, 2001
[Combination therapy with buserelin and tamoxifen in metastatic breast cancer in premenopause: a randomized study]K Willeke, H J Illiger
Medizinische Klinik (Munich, Germany : 1983)|February 15, 1996
[Integration of G-CSF in prevention and therapy of neutropenic fever]R Siegmund, H J Illiger
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Der Internist|September 9, 2000
[Quality assurance in oncology--medical oncology in particular]H J Illiger
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 11, 2002
[Superiority of letrozole compared with tamoxifen as first line therapy of postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group]H J Illiger
Medizinische Klinik (Munich, Germany : 1983)|January 15, 1994
[Ambulatory and/or inpatient oncologic treatment?]H J Illiger
Der Internist|February 12, 1998
[Monoclonal antibody 17-1A (Panorex). A new approach to adjuvant therapy of colonic carcinoma]H J Illiger
Der Internist|May 1, 1997
[Glucocorticoids in hematology and medical oncology]H J Illiger
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 29, 2000
[Primary prevention of breast cancer in women with an increased risk for breast cancer--a prospective, randomized, double-blind study (NSABP-P1 study)]D Reichert, H J Illiger
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 8, 2001
[Vinorelbine in patients with malignant pleural mesothelioma--a phase II study]E Ost, H J Illiger
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 10, 2001
[IFN-alpha consolidation after intensive chemotherapy does not bring any survival advantage in low-grade non-Hodgkin lymphoma]M Klee, H J Illiger
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 12, 2001
[Combination therapy with buserelin and tamoxifen in metastatic breast cancer in premenopause: a randomized study]K Willeke, H J Illiger
Medizinische Klinik (Munich, Germany : 1983)|February 15, 1996
[Integration of G-CSF in prevention and therapy of neutropenic fever]R Siegmund, H J Illiger
Pageof 7